PDF
Summary of National Advisory Committee on Immunization (NACI) Statement of January 28, 2022 : Rapid Response Guidance on the use of booster COVID-19 vaccine doses in adolescents 12-17 years of age
Organization: Public Health Agency of Canada (PHAC)Published: 2022
"This document provides a summary of the NACI Statement of January 28, 2022 : Guidance on the use of booster COVID-19 vaccine doses in adolescents 12-17 years of age." - Summary of National Advisory Committee on Immunization (NACI) Statement of January 28, 2022 Rapid Response: Guidance on the use of booster COVID-19 vaccine doses in adolescents 12-17 years of age
Resource Group:
Implementation Tool
Product Type: Guide
Vaccine Safety
Sub Topics: Vaccine Safety and Development
Research and Development
Vaccine Effectiveness and Efficacy
Program Planning and Delivery
Clinics
Specific Populations
Children
Adolescents
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Product Type: Guide
Category:
Vaccine Safety and Development,Vaccine Safety,Sub Topics: Vaccine Safety and Development,Research and Development,Vaccine Effectiveness and Efficacy,Program Planning and Delivery,Clinics,Specific Populations,Children,Adolescents,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccine Safety and DevelopmentVaccine Safety
Sub Topics: Vaccine Safety and Development
Research and Development
Vaccine Effectiveness and Efficacy
Program Planning and Delivery
Clinics
Specific Populations
Children
Adolescents
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Language:
English
Link
AudioResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.